Evidence map›Paper›PMID 41771913›Full record

ArticleNature communications2026

Epitope-spanning antigenic variation reprograms immunodominance and broadens immunity in sequential influenza vaccination.

Xiu-Feng Wan, Minhui Guan, Pradeep Balamalaliyage, Hanqiao Chen, Kritika Prasai, Ana Alcala, John Driver, Alicia K Olivier, Weihong Gu, Christina Frymire and 15 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Xiu-Feng Wan *NextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA. wanx@missouri.edu.ORCID http://orcid.org/0000-0003-2629-9234
Minhui Guan *NextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
Pradeep Balamalaliyage *NextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
Hanqiao Chen *Department of BioSciences, Rice University, Houston, TX, USA.
Kritika Prasai *NextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.ORCID http://orcid.org/0009-0004-8749-5719
Ana Alcala *NextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
John DriverNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
Alicia K OlivierDepartment of Pathobiology and Population Medicine, College of Veterinary Medicine, Mississippi State University, Mississippi State, Starkville, MS, USA.
Weihong GuNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
Christina FrymireNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
De Darling Melany Carvalho MadridNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
Cheng GaoNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
Chengcheng WangNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
Tao LiViral Diseases Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Wikanda TunterakNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
Qiongying YangNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
Ashwin RameshNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.ORCID http://orcid.org/0000-0002-4009-6823
Muzaffar AliNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
David SmithDepartment of Pathobiology and Population Medicine, College of Veterinary Medicine, Mississippi State University, Mississippi State, Starkville, MS, USA.ORCID http://orcid.org/0000-0002-8547-7486
Lei LiDepartment of Chemistry and Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-1146-0761
Andrea J SantDepartment of Microbiology and Immunology, Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.ORCID http://orcid.org/0000-0001-7176-7426
Jun HangViral Diseases Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Hang XieDivision of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.ORCID http://orcid.org/0000-0001-8318-5554
Mingyi ZhouNextGen Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, USA.
Yizhi Jane TaoDepartment of BioSciences, Rice University, Houston, TX, USA.

Funding

Impact of repeated vaccination on the effectiveness of seasonal influenza vaccinesR01AI152521 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI WAN, XIUFENG HENRY · 2020 to 2025
$3.7M
Use of Clinical Samples to Identify Influenza Virus Antigenic VariantsR01AI147640 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI WAN, XIUFENG HENRY · 2019 to 2024
$2.8M
NIAID NIH HHS R01 AI147640NIAID NIH HHS R01 AI152521U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI147640
6 · The paper itself

Abstract

Immune imprinting, in which prior antigenic exposures biases recall toward dominant epitopes, constrains the breadth and durability of influenza vaccine protection. Here we show that targeted variation across multiple hemagglutinin (HA) head sites (A, B, and D) between sequential A(H3N2) vaccines reprograms epitope hierarchy-redirecting recall toward conserved, subdominant head and stem epitopes. In a controlled ferret model mimicking imprinting-like recall in humans, antigenically distant priming accelerates neutralizing antibody induction, broadens reactivity, enhances cross-protection, and reduces viral shedding after drifted virus challenge. Epitope mapping and structural analysis confirms redirection toward conserved epitopes; single-cell transcriptomics and ELISpot assays reveal amplified germinal center B cell and Th1 responses. This "epitope hierarchy reshaping" links targeted antigenic variation to enhanced B cell competition, amplified T cell help, and improved viral control. This principle is likely applicable to vaccines against other rapidly evolving viruses where strong imprinting effects similarly limit immune breadth.

Indexed as

Antigenic VariationImmunodominant EpitopesInfluenza A Virus, H3N2 SubtypeInfluenza VaccinesAnimalsAntibodies, NeutralizingAntibodies, ViralB-LymphocytesEpitope MappingEpitopesFemaleFerretsHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza, HumanOrthomyxoviridae InfectionsAntibodies, NeutralizingAntibodies, ViralEpitopesHemagglutinin Glycoproteins, Influenza VirusImmunodominant EpitopesInfluenza Vaccines

Identifiers

PMID41771913
PMCPMC13066623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.